BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29866440)

  • 21. MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.
    Neumann CKA; Silver DJ; Venkateshwari V; Zhang R; Traughber CA; Przybycin C; Bayik D; Smith JD; Lathia JD; Rini BI; Brown JM
    Mol Metab; 2020 Apr; 34():136-145. PubMed ID: 32180553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
    Wang W; Gan Z; Liu Q; Yan S; Mulati R; Wang Y
    Bioengineered; 2021 Dec; 12(1):2957-2969. PubMed ID: 34180759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
    Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
    Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
    Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2.
    Gao Y; Ma X; Yao Y; Li H; Fan Y; Zhang Y; Zhao C; Wang L; Ma M; Lei Z; Zhang X
    Oncotarget; 2016 Apr; 7(15):20324-37. PubMed ID: 26967247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
    Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
    Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
    Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
    Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
    Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
    Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
    FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas.
    Théoleyre S; Mottier S; Masson D; Denis MG
    Biochem Biophys Res Commun; 2010 Apr; 394(3):453-8. PubMed ID: 19951697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability.
    Chen S; He Z; Peng T; Zhou F; Wang G; Qian K; Ju L; Xiao Y; Wang X
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34499617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.
    Rooney N; Mason SM; McDonald L; Däbritz JHM; Campbell KJ; Hedley A; Howard S; Athineos D; Nixon C; Clark W; Leach JDG; Sansom OJ; Edwards J; Cameron ER; Blyth K
    Cancer Res; 2020 Jun; 80(11):2325-2339. PubMed ID: 32156779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice.
    Johansson E; Rönö B; Johansson M; Lindgren D; Möller C; Axelson H; Smith EM
    Sci Rep; 2016 Aug; 6():30739. PubMed ID: 27491826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression.
    Feng Y; Li F; Yan J; Guo X; Wang F; Shi H; Du J; Zhang H; Gao Y; Li D; Yao Y; Hu W; Han J; Zhang M; Ding R; Wang X; Huang C; Zhang J
    Life Sci; 2021 Dec; 287():120056. PubMed ID: 34687756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma.
    Xiao H; Qu Y; Li H; Zhang Y; Fei M; Liang C; Yang H; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):29. PubMed ID: 38263248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
    Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
    J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer.
    Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X
    Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
    Mizutani A; Koinuma D; Seimiya H; Miyazono K
    Oncogene; 2016 Jul; 35(27):3514-23. PubMed ID: 26522722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.